NEUROIMAGING CHARACTERISTICS OF ENCEPHALOPATHY IN CHRONIC KIDNEY DISEASE
Abstract
According to WHO, vascular diseases of the brain in the developed countries of the world account for 15% of the total mortality. At the same time, acute and chronic encephalopathies occupy a special place in the structure of vascular diseases. In recent years, special attention has been paid to encephalopathies developing as a result of renal pathology, since kidney diseases, namely chronic kidney disease (CKD) is a huge socio-economic problem that leads to cerebral complications, with a significant deterioration in the quality of life, a sharp loss of working capacity, and a high percentage of mortality. In the diagnosis of various encephalopathies and other disorders of cerebral circulation, an invaluable role is played by MRI, MSCT, brain angiography with their wide diagnostic capabilities.
Similar Articles
-
Medical Problems In Patients With Alcohol Dependence With Common Schizophrenia And Schizoaffective Disorder
The American Journal of Medical Sciences and Pharmaceutical Research: No. 12 (2020) / S.Sh. Karimova , Yu.Y. Ergasheva , -
IMPACT OF COVID-19 ON THE PROFILE, SEASONALITY AND INCIDENCE OF FEMUR FRACTURE CASES IN BRAZILIAN YOUNG ADULTS
The American Journal of Medical Sciences and Pharmaceutical Research: No. 11 (2023) / Eduardo Romera Alves de Souza, Fábio Lucas Rodrigues, Matheus Marques Ferreira, Pedro Bernardi Soares de Camargo, Gabriel Hassan Choucair, -
TO DETERMINE THE EFFECT OF AYURVEDA MEDICATION IN THE MANAGEMENT OF ESSENTIAL HYPERTENSION
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2023) / Dr.Smita Naram, Dr.Deepak Mahajan, Dr.Hemang Parekh, Dr.Tushar Yadav, -
Assessment Of Factors Of Vascular Wall Damage In Depressive Disorders In Patients With Myocardial Infarction
The American Journal of Medical Sciences and Pharmaceutical Research: No. 12 (2020) / Mukhamadieva N.B., -
Microscopic Examination Of Postcapillary Cerebral Venues In Hemorrhagic Stroke
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2021) / Khaidarov Nodir Kadyrovich, Shomurodov Kahramon Erkinovich , Kamalova Malika Ilhomovna, -
Definition Of Endometrial Immune Dysfunction In Recurrentpregnancy Loss
The American Journal of Medical Sciences and Pharmaceutical Research: No. 12 (2020) / Nigora Abdugaffarovna Mamasalieva , Shoxista Abdugapparovna Mamasolieva , Maftuna Daughteraziz Abdullaeva , -
Correction Of Cognitive Disorder In Patients With HIV - Associated Encephalopathy
The American Journal of Medical Sciences and Pharmaceutical Research: No. 07 (2020) / Zokirov M.M.,, Madjidova Y.N., -
INITIAL STATE OF COCHLEOVESTIBULAR FUNCTION IN PATIENTS WITH HD WITH CVD
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2022) / Ulugbek S. Khasanov, Nazim A. Akhundjanov, Azizkhon Z. Shaumarov, Jamolbek A. Djuraev, -
Climate Change And Human Health
The American Journal of Medical Sciences and Pharmaceutical Research: No. 10 (2020) / Axrorova Malika Shavkatovna, Arzikulova Munisa Shuhratovna, Rahimberdiev Rustam Abdurashidovich, Shukurov Sherzod Shukhratovich, -
Conceivable Focal Job Of Oxytocin In Neurobehaviour Of Male Rodents And Mice
References
Chronic kidney disease: Clinical guidelines / Association of Nephrologists of Russia, 2019. Russian (Chronic Kidney disease: Clinical recommendations / Association of Nephrologists of Russia, 2019. URL: http://nonr.ru / wp-content / uploads / 2020 / 01 / Clin_guidlines_CKD_24.11_final-3–3. pdf (March 12, 2020)).
Rogova IV, Fomin VV, Damulin IV, et al. Vascular cognitive impairments in chronic kidney disease. Neurology, Neuropsychiatry, Psychosomatics 2015; 7 (1): 11–8. Russian (Rogova I. V., Fomin V. V., Damulin I. V., etc. Vascular cognitive impairment in chronic kidney disease. Neurology, neuropsychiatry, psychosomatics 2015; 7 (1): 11-8).
Mark PB. Strategies to manage cardiovascular risk in chronic kidney disease. Nephrology Dialysis Transplantation 2017; 33 (1): 23–5.
Nikitina AA, Khrulev AE. Cerebrovascular disorders of the predialysis period of chronic kidney disease and development mechanisms. Medical Almanac 2018; 56 (5): 28–32. Nikitina A. A., Khrulev A. E. Cerebrovascular disorders of the predialysis period of chronic kidney disease and the mechanisms of their development. Medical Almanac 2018; 56 (5): 28-32).
Khrulev AE, Studyanikova SF, Langraf SV, et al. Cognitive impairment in patients on hemodialysis. Neurology Bulletin 2019; 51 (2): 36–40. Russian (Khrulev A. E., Studyanikova S. F., Langraf S. V., etc. Cognitive impairment in patients undergoing programmed hemodialysis. Neurological Bulletin 2019; 51 (2): 36-40).
Nathan E., Penersen S.E. Dialysis encephalopathy // Acta.Pediatrics. Scand. ― 1980. ― №69. ― P. 793-796.
Raskin Neil H. Neurological Aspects of Renal Failure //Neurology and general medicine / Ed. by M.J. Aminoff. ― 3rd ed. ―2001. ― P. 231-246.
Etgen T, Chonchol M, Förstl H, Sander D. Chronic kidney disease and cognitive impairment: A systematic review and meta-analysis. Am J Nephrol 2012; 35 (5): 474–82.
Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clinic Proceedings. 2010;85:427-432. https://doi.org/10.4065/mcp.2009.0590
Ahn KJ, You WJ, Jeong SL, Lee JW, Kim BS, Lee JH, Yang DW, Son YM, Hahn ST. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology. 2004;46(12):978-983. https://doi.org/10.1007/s00234-004-1276-1
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. The Lancet Neurology. 2015;14(9):914-925. https://doi.org/10.1016/s1474-4422(15)00111-8
Stevens CJ, Heran MKS. The many faces of posterior reversible encephalopathy syndrome. The British Journal of Radiology. 2012;85(1200):1566-1575. https://doi.org/10.1259/bjr/25273221
Garg RK. Posterior leukoencephalopathy syndrome. Postgraduate Medical Journal. 2001;77(903):24-28. https://doi.org/10.1136/pmj.77.903.24
Zeeman GG. Neurologic complications of Pre-eclampsia. Seminars in Perinatology. 2009;33(3):166-172. https://doi.org/10.1053/j.semperi.2009.02.003
Skvortsova V.I., Gubsky L.V., Melnikova E.A. Posterior reversible encephalopathy syndrome. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2010;110(5):104-109. Skvortsova VI, Gubskiy LV, Melnikova EA. Posterior reversible encephalopathy syndrome. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2010;110(5):104-109. (In Russ.).
Chou SO, Lai PH, Yeh LR, Yuan MK, Liang HL, Chen C, Pan HB, Yang CF, Li JY, Lo YK. Posterior reversible leukoencephalopathy syndrome: magnetic resonance imaging and diffusion-weighted imaging in 12 cases. The Kaohsiung Journal of Medical Sciences. 2004;20(8):381-388. https://doi.org/10.1016/s1607-551x(09)70174-3
Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez RG, Koroshetz WJ. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology. 1998;51:1369-1376. https://doi.org/10.1212/wnl.51.5.1369
Zeeman GG. Neurologic complications of Pre-eclampsia. Seminars in Perinatology. 2009;33(3):166-172. https://doi.org/10.1053/j.semperi.2009.02.003
Kastrup O., Schlamann M., Moenninghoff C., Forsting M., Goericke S. Posterior reversible encephalopathy syndrome: the spectrum of MR imaging patterns. Clin. Neuroradiol. 2015; 25(2): 161–71. DOI: 10.1007/s00062-014-0293-7).
